ELUT Q3 2024 Earnings — Elutia Inc. Revenue & Financial Results | Market Cap Arena

ELUTElutia Inc.

$48M

Q3 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6M-3.3% YoY

Gross Profit

$3M46.3% margin

Operating Income

-$10M-172.7% margin

Net Income

$1M21.7% margin

EPS (Diluted)

$-0.33

QoQ Revenue Growth

-5.9%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$4M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$48M

Total Liabilities

$89M

Stockholders' Equity

-$40M

Cash & Equivalents

$26M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$6M	-3.3%
Gross Profit	$3M	$3M	-3.5%
Operating Income	-$10M	-$7M	-38.8%
Net Income	$1M	-$10M	+113.2%

Revenue Segments

Women's Health

$3M85%

Cardiovascular

$562,00015%